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Abstract
Background: Protein kinases are involved in diverse spectrum of cellular processes. Availability
of draft version of the human genomic data in the year 2001 enabled recognition of repertoire of
protein kinases. However, over the years the human genomic data is being refined and the current
release of human genomic data has helped us to recognize a larger repertoire of over 900 human
protein kinases represented mainly by splice variants.
Results: Many of these identified protein kinases are alternatively spliced products. Interestingly,
some of the human kinase splice variants appear to be significantly diverged in terms of their
functional properties as represented by incorporation or absence of one or more domains. Many
sets of protein kinase splice variants have substantially different domain organization and in a few
sets of splice variants kinase domains belong to different subfamilies of kinases suggesting potential
participation in different signal transduction pathways.
Conclusions: Addition or deletion of a domain between splice variants of multi-domain kinases
appears to be a means of generating differences in the functional features of otherwise similar
kinases. It is intriguing that marked sequence diversity within the catalytic regions of some of the
splice variant kinases result in kinases belonging to different subfamilies. These human kinase splice
variants with different functions might contribute to diversity of eukaryotic cellular signaling.
Background
Protein kinases represent one of the largest protein
domain families in most of the higher eukaryotes. Mem-
bers of protein kinase family are involved in innumerable
signal transduction pathways contributing in the decision
making on variety of cellular processes such as cell
growth, development, differentiation, metabolism, cell
communication and apoptosis. Availability of the first
draft version of the human genomic data in the year 2001
[1] provided opportunity to recognize the repertoire of
protein kinases in the human [2-4]. These studies
employed bioinformatics approaches to recognize kinases
starting from the genomic data and provided a classifica-
tion of kinases that give hint to the signal transduction
pathways in which the kinases participate. Due to differ-
ences in the human genome data set employed and also
due to different bioinformatics approaches employed by
different groups the number of protein kinases reported in
these early publications differed slightly though a vast
majority of kinases forming a common set [5].
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BMC Genomics 2009, 10:622 http://www.biomedcentral.com/1471-2164/10/622Quality of the human genomic data is being continuously
improved since its first release in 2001 [1]. In the early
draft dataset the order of the base pairs in each chromo-
somal area has been determined 4 or 5 times (4× or 5×) or
even more [1]. However in April 2003 human genome
data of better quality was compiled in which additional
sequencing improved the accuracy significantly http://
www.ornl.gov/TechResources/Human_Genome/project/
50yr.html. With the improvements in genome sequencing
projects, order of the base pairs in each chromosomal area
has been determined 8 or 9 times (8× or 9×) and the qual-
ity of the human genomic data improved significantly
over the time. The present version of the human genomic
data and the annotation are of superior quality compared
to the first release about 8 years ago. This accurately anno-
tated genomic sequence data set has impact in the quality
of other kinds of genome-wide data sets such as, transcript
sequences, expression data, disease influenced gene regu-
lation and functional information.
Alternative splicing is an important mechanism to
increase proteomic diversity [6] which produces diverse
transcripts and hence potentially diverse protein products
from the same gene locus which eventually add significant
complexity to the genome. In typical alternative splicing
process different combinations of exons within a gene are
spliced from RNA precursor and reassembled in the
mature mRNA. The nature of splice variant could be fur-
ther related to the tissue type, developmental stage and
disease versus normal conditions of the cell. Thus splicing
could result in multitude of proteins originating from sin-
gle gene and these protein products often have interesting
diversity in functional properties. For example Drosophila
Dscam gene, an axon guidance receptor gene, is a striking
example which produces more than a thousand gene
products [7]. Alternative splicing mechanism has been
studied for various mammalian systems as well as for
plants [[8-11]; http://www.itb.cnr.it/kinweb]. Analysis of
some of the human kinase splice variants has been per-
formed in the past [[11]; http://www.itb.cnr.it/kinweb]
which also gives information about their domain combi-
nation. Though human and mouse are very close mam-
malian species, it has been observed that the conservation
of alternative splicing pattern is low [12-14] which might
be the reason for the generation of species-specific gene
products. Though the human kinome analysis performed
in 2001 [2-4] identified over 500 kinases, it was earlier
anticipated that the number of human protein kinases
might be around 1000 [15]. We suggest that higher esti-
mate still holds good as the splicing mechanism in human
is very common. Bioinformatics analysis indicates that
approximately 40-60% of the human genes are known to
alternatively spliced [16-19] with majority of splicing
events occurring in 5' untranslated regions. Splicing event
allows production of more than one protein isoform from
a single gene which may have altered substrate affinities,
sub-cellular localizations, and may exhibit different and
sometimes antagonistic functional and structural proper-
ties [20-22]. In fact, various protein kinase splice variants
have been experimentally characterized and they are
shown to elicit different expression patterns, differential
localization and hence different functional properties [23-
26]. It is known from a previous study that alternative
transcripts of protein kinases encode different domain
structures and these variants are likely to play important
roles in phosphorylation-dependent signaling pathways
[8]. Splice variants of human centrosome kinase Nek2 are
known to exhibit different pattern of expression in mitosis
[24]. Two splice forms of human protein kinase B are
shown to have distinct regulatory capacity depending
upon presence or absence of phosphorylation site in the
carboxy terminal hydrophobic domain [27]. Two splice
forms of Mitogen-activated protein (MAP) kinase-inter-
acting kinase (Mnk) derived from same gene differ only at
their C termini. It has been seen that while Mnk2a con-
tains a MAP kinase-binding site in this region, Mnk2b
lacks such a sequence and is much less readily activated by
MAP kinases in vitro. Mnk2a is cytoplasmic whereas sub-
stantial amount of Mnk2b is found in the nucleus [25].
Splice variants of Serum and Glucocorticoid-Inducible
Kinase 1 (SGK1) which belongs to AGC group of protein
kinase known to be regulated differentially following dif-
ferentiation and shown to be markedly upregulated in
tumor tissues [28]. TrkC, a receptor tyrosine kinase has a
number of naturally occurring splice variants including
one with a 14 residues insertion between subdomain VII
and VIII in the C-terminal lobe of the kinase domain. This
insert in the catalytic domain of TrkC results in defective
MAPK activation which may result predominantly from
an inhibition of high-affinity Shc binding [29]. Splicing
mechanism is very carefully regulated as aberrant regula-
tion of alternative splicing in human has been implicated
in various diseases [30,31].
Most of the analyses on identification and analysis of
comprehensive collection of human gene splice products
have been performed before or around the time when the
first draft of the human genome sequence data was
released. Thus, these analyses were performed using
incomplete set of human gene products. Moreover,
despite availability of complete human genomic data in
the subsequent years, the improvement in the quality of
the genomic data has been gradual which has prompted
us to identify and analyse repertoire of protein kinase
gene products with the present information on splice var-
iants of human kinases. Our objective in this analysis is to
extend our understanding of repertoire of functions of
human protein kinases and extent to which the functional
diversity could occur among splice variants of human
kinases.Page 2 of 7
(page number not for citation purposes)
BMC Genomics 2009, 10:622 http://www.biomedcentral.com/1471-2164/10/622Results and discussion
Identification and analysis of a comprehensive collection 
of human protein kinases
Currently, there are two online sites that constantly
update the information on repertoire of human protein
kinases gleaned periodically from the releases of human
genome data. These data sets KinG [Kinases in Genome
http://hodgkin.mbu.iisc.ernet.in/~king] [32] and
kinase.com http://kinase.com/kinbase/FastaFiles/ are
quite similar in terms of list of human kinases and their
classification into subfamilies. Both these datasets of
human kinome are obtained as a result of careful use of
highly sophisticated sequence analysis tools. For example,
in the recent releases of KinG database http://hodg
kin.mbu.iisc.ernet.in/~king, we have employed highly
sensitive multiple profile search approach [33,34]. During
this update of the database and analysis many protein
kinases have come into light which are splice variants of
previously identified protein kinases listed in various
kinome datasets such as the one in http://www.itb.cnr.it/
kinweb[11]. This prompted us to extend and analyse the
repertoire of protein kinase gene products by including
protein kinase splice variants in the dataset. The improved
human genome data enriched with information on splice
variants available in ENSEMBL database http://
www.ensembl.org/Homo_sapiens/index.html has helped
us to analyze protein kinase splice variants which were not
studied in the previous genome-wide studies on kinases
using the draft version of human genomic data [2-4].
In the current analysis, using various sensitive profile
search methods (discussed in Materials and Methods sec-
tion), we report 918 putative human protein kinase gene
products (Additional file 1). In addition this list inte-
grated with user-friendly search options is also available
as a part of KinG database at http://hodg
kin.mbu.iisc.ernet.in/king/cgi/search. All these 918
kinase gene products have catalytic aspartate, which acts
as catalytic base, suggesting that these gene products are
likely to possess phosphotransferase activity. Sequences
lacking the catalytic aspartate (protein kinase-like non-
kinases) have not been included in the current list. There
are 445 genes which are encoding 918 protein kinase
products. There are 209 genes which are encoding only
one protein kinase. Remaining 236 kinase genes give rise
to more than one gene product which are splice variants.
Maximum number of splice variants generated from a
protein kinase gene is 12.
We checked for the expression of the human protein
kinase splice variants using the publicly available cDNA
data ftp://ftp.ensembl.org/pub/current_fasta/
homo_sapiens/cdna/ and found that 894 out of 918 have
known cDNA data. Hence overwhelming majority of the
recognized protein kinase genes is probably expressed and
represents functional proteins. We have compared our
kinome data set to kinase.com http://www.kinase.com in
which so far 516 protein kinase gene products have been
listed of which 25 are atypical protein kinases which are
different from typical eukaryotic protein kinase super-
family discussed in the current analysis.
Classification of protein kinase gene products
These putative protein kinases have been further classified
into various subfamilies as proposed by Hanks and
Hunter [35]. The most represented protein subfamily in
human is CAMK (Ca2+/Calmodulin dependent Protein
Kinase) (Additional file 1 and http://hodg
kin.mbu.iisc.ernet.in/king/cgi/search) group of protein
kinases regulated by Calcium/Calmodulin having 161
members which is followed by CMGC (CDK, MAPK,
GSK3, CK2) group of protein kinases which have 149
members. There are 130 protein products belonging to
AGC group of kinases which are mainly second messenger
regulated kinases. Several members which are closely
related to protein tyrosine kinase family and Tyrosine
kinase-like (TKL) subfamily have also been identified.
TKL family is quite diverse which have members (e.g. Raf,
Mixed-lineage kinase, Activin and beta-receptor kinase,
Interleukin 1 receptor associated kinase etc.) resembling
both tyrosine and Serine/Threonine kinase families.
Human kinases splice variants with potentially diverse 
functions: revealed from sequence analysis
Interestingly there are examples of newly recognized
splice variants encoded by a single gene which differ
markedly in length and have different domain organiza-
tion. Such prominent differences indicate that these splice
variants might have different mode of regulation and dif-
ferent functional properties. Additional File 2 represents
set of such protein kinase splice variants which have dif-
ferent domain organisation. For example while two pro-
tein kinases (ENSP00000300843 and
ENSP00000262893) with their catalytic domains closely
resembling MARK subfamily has UBA (Ubiquitin-associ-
ated domain) domain following the kinase domain; how-
ever a splice variant (ENSP00000262891) has an extra
domain, KA1 (Kinase-associated domain), apart from
kinase and UBA domains (Figure 1A). KA1 domain teth-
ered to protein kinase catalytic domain indicates a role of
this kinase in ubiquitin pathway. Similarly, regulatory
domain CAMII_AD domain which has role in multimeri-
zation is usually found tethered to the Calcium/Calmod-
ulin dependent protein kinase II (CAMKII). CAMII_AD
domain is absent in one of the splice variants which has a
kinase domain closely related to CAMKII subfamily
(ENSP00000369096) while this regulatory domain is
present in three splice variants (ENSP00000339740,
ENSP00000378032, ENSP00000378034) (Figure 1B). In
the same way, one of the four splice variantsPage 3 of 7
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ENSG00000010810 lacks SH3 domain which is found
tethered N-terminal to the Fyn tyrosine kinase (Figure 1C)
which has role in increasing local concentration of pro-
teins, altering their subcellular location and mediating the
assembly of large multiprotein complexes. Interestingly,
two splice variants (ENSP00000339291,
ENSP00000339299) encoded by the gene
ENSG00000038382 which belong to Trio subfamily of
CAMK group regulated by calmodulin, may mediate
apoptosis induced by interferon-gamma [36], have also
different domain organizations. In this example one of
the members (ENSP00000339299) has multiple domains
like spectrin repeats, two copies of Rho GEF and PH
domain, SH3 and I-set (Immunoglobulin) domains
whereas another variant (ENSP00000339291) is lacking
all these domains except I-set domain which is in the N-
terminus of the kinase domain (Figure 1D). There are
many more splice variants which are encoded by the same
gene but lack one or more regulatory accessory domains
and these are listed in Additional file 2.
Additional file 2 also lists few examples of splice variants
which are encoded by same gene but their catalytic kinase
domain belong to different protein kinase subfamilies.
For example from a set of six splice variants
(ENSP00000320622, ENSP00000346846, ENSP000
00352088, ENSP00000353452, ENSP00000353530,
ENSP00000355024) encoded by the gene
ENSG00000065534 five splice variants belong to MLCK
(Mixed Lineage Chain Kinase) subfamily whereas one of
the splice variants belong to DRAK (death-associated pro-
tein kinase [DAP-kinase]-related apoptosis-inducing
kinase) subfamily which plays important roles in apop-
totic signal transduction [37]. There is another example in
which one of the four splice variants (ENSP
00000354170) encoded by ENSG00000068078 gene
belong to Vascular Endothelial Growth Factor protein
tyrosine kinase subfamily whereas other three
(ENSP00000231803, ENSP00000260795, ENSP00
000339824) belong to Fibroblast growth factor receptor
subfamily (Additional file 2).
Expression of human kinases splice variants in different 
cell types
Additional file 3 provides information on expression of
many human kinase splice variants in different tissue or
cell types. This information was obtained from ENSEMBL
database. From this Table it can be observed that at least
one splice variant product from each of 44 genes is
expressed in two or more different tissues compared to
other splice variants corresponding to the same gene. This
number represents a proportion of ~49% of the genes
implicated in variant splicing. In all such cases splice var-
iants corresponding to a gene belong to the same kinase
subfamily. For example, the gene ENSG00000141068
produces two kinases belonging to the same sub-family,
one expressing in 4 tissues (ENSP00000323178) and the
other expressing in 17 tissues (ENSP00000268763).
Conclusions
Remarkable improvement in the quality of human
genomic data enabled us to generate a more comprehen-
sive repertoire of human kinases with identification of
918 protein kinase gene products with many of these rep-
resenting splice variants with altered properties. Previous
analyses on human kinome [1-3] presented much smaller
set of kinases as splice variants were not analyzed in these
early papers. Indeed Milensi et al [11] extended the early
analysis of human kinome considering splice variation
and, in particular, reported 5 further kinase genes and a
pseudogene. However, present study indicates that the
alternative splice forms of protein kinase genes are far
more abundant than previously thought and seems to
provide interesting variety with implications in biological
pathways and processes. Present analysis has unearthed
newly recognized protein kinase splice variants with
Cartoon representation of domain organization of newly rec-ognized splice variants encoded by a single gene which hav  differ nt domain organizati nFigure 1
Cartoon representation of domain organization of 
newly recognized splice variants encoded by a single 
gene which have different domain organization. Splice 
variants shown in the figure are closely related to a) MARK 
kinase; b) CAMK II subfamily; c) Fyn tyrosine kinase d) Trio 
kinase. Abbreviations followed in the figure: UBA, Ubiquitin 
Associated Domain; KA1, Kinase Associated Domain 1; 
CAMKII_AD, Calcium/calmodulin dependent protein kinase 
II Association; SH3, Src homology 3; SH2, Src homology 2; I-
set, Immunoglobulin domain; RhoGEF, Guanine nucleotide 
exchange factor for Rho/Rac/Cdc42-like GTPases; PH, Pleck-
strin Homology domain.Page 4 of 7
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and many of them known to get expressed in various tis-
sue or cell types. Our current survey enabled us to recog-
nize many important kinase splice variants which might
be involved in diverse signal transduction pathways and
have different modes of regulation. List of newly recog-
nized human kinase splice variants includes several exam-
ples which are not yet studied experimentally. Future
direction could aim at studying sub-cellular localization
of the kinase splice variants in the types of cells, their role
in biological processes, modes of regulation and substrate
specificity which will give insight into the human signal
transduction pathway.
Methods
The complete set of predicted protein sequences from the
ORFs of the human genome has been obtained from
ENSEMBL [release 52] http://www.ensembl.org. We have
surveyed the genome, for Ser/Thr and Tyr protein kinases
using sensitive sequence profile matching algorithms. The
sequence search tools and other strategies for domain
identification and sub-family classification used in this
study by employing PSI-BLAST [38], Reverse PSI - BLAST
(RPS-BLAST) [39], HMMer [40] which match Hidden
Markov Models (HMMs) to identify protein kinase cata-
lytic domain and their co-occurring domains. Search pro-
cedures such as PSI-BLAST and RPS-BLAST have been used
at stringent E-value cut off of 0.0001. Searches performed
using HMMer with an E-value cut-off of 0.01 or below
have been shown to nearly eliminate any spurious hits.
Hits lacking significant sequence similarity with the query
have been further examined, manually. The final data set
of predicted putative human protein kinases has been
obtained from the compilation of hits obtained using var-
ious procedures. The program CD-HIT [41] was used in
order to eliminate redundant sequences. The sequence
identity shared between any two putative protein kinase
sequences in the data set is less than 100%, suggesting that
the data set is devoid of redundant sequences. Multiple
sequence alignment of the kinase catalytic domains of the
putative human protein kinases has been carried out
using ClustalW [42]. Information on cell/tissue types
where various kinases are expressed has been retrieved
from ENSEMBL http://www.ensembl.org and it has been
observed that 498 protein kinases are getting expressed in
various tissue types (Additional file 3).
Classification of human protein kinases into subfamilies
Protein kinases discussed in the current analysis have
been classified into various protein kinase subfamilies
proposed by Hanks and Hunter classification scheme.
RPS-BLAST has been used to search each of the putative
protein kinases as a query against the database containing
55 Multiple Position Specific Scoring Matrices
(MulPSSMs) created for the various subgroups of protein
kinases in each of the subfamilies. Criteria used in identi-
fying kinase subfamilies involved use of stringent condi-
tions such as alignment coverage of the sequence greater
than 70% over the kinase domain region and sequence
identity cut-off of 30% aside from satisfying the stringent
e-value cutoff criteria.
Domain assignment to the non-catalytic regions of the
kinase containing genes has been carried out using the
HMM search methods by querying each of the kinase
domain containing sequences against the 9318 protein
family HMMs available in the Pfam database release 23
[43].
Information on splice variants for these putative protein
kinases was taken from BioMart data mining tool availa-
ble in ENSEMBL database which has entry for genes, their
transcripts and protein products. In ENSEMBL, an initial
alignment of mRNA and protein is performed against the
genome. All overlapping transcripts are clustered under
one gene name and deemed 'splice variants'. So the gene
products pointing to a single gene are defined as splice
variants by ENSEMBL http://www.ensembl.org.
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